<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01422525</url>
  </required_header>
  <id_info>
    <org_study_id>OCT-TET</org_study_id>
    <nct_id>NCT01422525</nct_id>
  </id_info>
  <brief_title>Changes of the Peripapillary Retinal Nerve Fiber Layer After Filtration Surgery in Glaucoma Patients</brief_title>
  <official_title>Effect of Trabeculectomy on Peripapillary Retinal Nerve Fiber Layer Thickness Using Spectral Domain Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Eye Hospital, Würzburg</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Eye Hospital, Würzburg</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      At present, trabeculectomy is the most common performed and effective surgical method of
      filtration surgery for patients with medically uncontrolled glaucoma.

      The aim of this prospective observational case study is to determine changes of the
      peripapillary retinal nerve fiber layer thickness using spectral domain optical coherence
      tomography in patients with glaucoma after surgical reduction of intraocular pressure.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Baseline and postoperative measurement of the peripapillary retinal nerve fiber layer (RNFL)
      thickness will be performed using the following spectral domain optical coherence tomography
      (OCT): Cirrus™ HD-OCT (Carl Zeiss Meditec) and Spectralis® Heidelberg-Engineering.

      The main outcome measures will be changes in overall and quadrant RNFL thickness with respect
      to reduction in intraocular pressure (IOP), correlation between RNFL thickness and alteration
      in visual field and predictive factors of postoperative IOP-reduction and changes of RNFL
      thickness.
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    short of study staff
  </why_stopped>
  <start_date>November 2011</start_date>
  <primary_completion_date type="Actual">February 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>change of retinal nerve fiber layer thickness</measure>
    <time_frame>6 months</time_frame>
    <description>study was terminated</description>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Actual">12</enrollment>
  <condition>Nerve Fiber Bundle Defect</condition>
  <condition>Optic Nerve Diseases</condition>
  <arm_group>
    <arm_group_label>Trabeculectomy RNFL thickness OCT</arm_group_label>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>spectral domain optical coherence tomography</intervention_name>
    <description>RNFL thickness measurement using spectral domain optical coherence tomography at baseline, 1, 3 and 6 months postoperatively.</description>
    <arm_group_label>Trabeculectomy RNFL thickness OCT</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        glaucoma patients
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  primary or secondary open angle glaucoma

          -  target intraocular pressure under medical treatment was not reached

          -  progression of visual loss

          -  best corrected visual acuity of 20/100 or more

          -  spherical equivalent refraction of -8.0 to +4.0 D

          -  perimetry: less than 20% false positive answers

        Exclusion Criteria:

          -  primary or secondary angle closure glaucoma

          -  congenital glaucoma

          -  normal tension glaucoma

          -  neovascular glaucoma
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>University Eye Hospital Wuerzburg</name>
      <address>
        <city>Wuerzburg</city>
        <state>Bavaria</state>
        <zip>97080</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>December 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>August 21, 2011</study_first_submitted>
  <study_first_submitted_qc>August 22, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 24, 2011</study_first_posted>
  <last_update_submitted>December 1, 2014</last_update_submitted>
  <last_update_submitted_qc>December 1, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">December 2, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Eye Hospital, Würzburg</investigator_affiliation>
    <investigator_full_name>Juliane Matlach, MD</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Nervous System Diseases</mesh_term>
    <mesh_term>Optic Nerve Diseases</mesh_term>
    <mesh_term>Retinal Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

